There’s Hope After Stroke
CBC Health is providing experimental cord blood infusions for individuals across the globe who have had an ischemic stroke. CBC Health is introducing an innovative paradigm for stroke recovery that is based on neuroregenerative medicine. Ischemic stroke victims who are treated by CBC Health professionals may benefit from regenerative improvements in the brain that could include:
Mediate restorative effects of progenitor cells
Neurotrophins reduce cell death and increase cell growth
Immune modulation and paracrine signaling stimulate cell repair
Promotes cellular healing and cell regeneration
Why Choose CBC Health’s Stroke Recovery Treatment Over Others
In comparison to other stem cell treatments for ischemic stroke, CBC Health only uses allogeneic cord blood stem cells, whereas, other companies use autologous stem cells. Autologous stem cell treatments require invasive procedures to harvest stem cells from the stroke patient prior to treatment. CBC Health uses cord blood that is readily available, tested and stored by Europe’s second-largest private cord blood repository, Cord Blood Center Group.
Allogeneic cord blood stem cells offer the following benefits when compared to autologous stem cells:
- Increased cell replacement
- Faster growth rates
- Neurotrophic Influence
- More immunologically beneficial
- Readily available
- More therapeutic cells and proteins
You or your loved ones may have questions about the science behind our Cord Blood Stroke Recovery treatment. Please read on or refer to our Frequently Asked Questions page.
Cord Blood Center Group, CBC Health’s parent company is both a public and private cord blood bank that manages its own laboratories. Over the past 20 years, it has been recognized for world-class quality and has earned international esteem.